Detlev Mennerich

Director/Board Member at

NBE-Therapeutics AG

57 year

16 connections

Health Technology

Consumer Services

Commercial Services

Profile

Detlev Mennerich is currently Director at NBE-Therapeutics AG, TACALYX GmbH, and T-Knife GmbH.
Formerly, Dr. Mennerich was Corporate Senior Vice President at Boehringer Ingelheim International GmbH from 2022 to 2025, Director at Rinri Therapeutics Ltd., and Chairman-Supervisory Board at Topas Therapeutics GmbH.
Education includes an undergraduate degree from Technische Universität Braunschweig in 1997 and a doctorate from Martin-Luther-Universität Halle-Wittenberg in 2000.

Detlev Mennerich active positions

Companies	Position	Start
Boehringer Ingelheim (Venture Capital) Boehringer Ingelheim (Venture Capital) Investment ManagersFinance BIVF invests in companies located across the globe including the United States, Europe and China. The firm targets companies operating in groundbreaking innovation including cancer, regenerative medicine, auto-immunity indications, digital solutions and infectious disease. It participaotes in seed and early stage capital requirements. The firm acquires minority interest and makes follow-on investments. It also takes seat on the board of directors.	Private Equity Investor	01/01/2014
TACALYX GmbH TACALYX GmbH Miscellaneous Commercial ServicesCommercial Services Develops therapeutics targeting cancer-specific carbohydrate antigens for metastatic malignant tumors	Director/Board Member	-
NBE-Therapeutics AG NBE-Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops antibody drug conjugates and advancing targeted cancer therapies	Director/Board Member	-
T-Knife GmbH T-Knife GmbH BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops novel therapeutics to fight cancer	Director/Board Member	-

All active positions of Detlev Mennerich

Former positions of Detlev Mennerich

Companies	Position	End
Boehringer Ingelheim International GmbH Boehringer Ingelheim International GmbH Pharmaceuticals: MajorHealth Technology Engages in development, manufacturing and marketing of medicines for humans & animals	Corporate Officer/Principal	01/01/2025
Topas Therapeutics GmbH Topas Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for immune tolerance	Chairman	-
Rinri Therapeutics Ltd. Rinri Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops regenerative stem cell-based therapies for treatment of hearing loss	Director/Board Member	-

See the detail of Detlev Mennerich's experience

Training of Detlev Mennerich

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Detlev Mennerich's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Technische Universität Braunschweig Technische Universität Braunschweig Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Martin-Luther-Universität Halle-Wittenberg Martin-Luther-Universität Halle-Wittenberg Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Boehringer Ingelheim International GmbH Boehringer Ingelheim International GmbH Pharmaceuticals: MajorHealth Technology Engages in development, manufacturing and marketing of medicines for humans & animals	Health Technology
Boehringer Ingelheim (Venture Capital) Boehringer Ingelheim (Venture Capital) Investment ManagersFinance BIVF invests in companies located across the globe including the United States, Europe and China. The firm targets companies operating in groundbreaking innovation including cancer, regenerative medicine, auto-immunity indications, digital solutions and infectious disease. It participaotes in seed and early stage capital requirements. The firm acquires minority interest and makes follow-on investments. It also takes seat on the board of directors.	Finance
NBE-Therapeutics AG NBE-Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops antibody drug conjugates and advancing targeted cancer therapies	Health Technology
Topas Therapeutics GmbH Topas Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for immune tolerance	Health Technology
Rinri Therapeutics Ltd. Rinri Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops regenerative stem cell-based therapies for treatment of hearing loss	Commercial Services
TACALYX GmbH TACALYX GmbH Miscellaneous Commercial ServicesCommercial Services Develops therapeutics targeting cancer-specific carbohydrate antigens for metastatic malignant tumors	Commercial Services
T-Knife GmbH T-Knife GmbH BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops novel therapeutics to fight cancer	Health Technology